Therapeutic Potential of Danyankang Capsule in High-Fat Diet-Induced Cholelithiasis and Its Impact on Liver FXR Signaling and Gut Microbiota-Reference-Cited by-同舟云学术

Therapeutic Potential of Danyankang Capsule in High-Fat Diet-Induced Cholelithiasis and Its Impact on Liver FXR Signaling and Gut Microbiota

Published:2024-03-22 Issue:3 Volume:47 Page:680-691
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Zhou Lin¹,Zhang Chu-Ling¹,Jiang Kun²,Cheng Hong-Yu³,Xiong Wen-Wen⁴,Zhu Ji-Xiao¹

Affiliation:

1. Research Center of Traditional Chinese Medicine Resources and Ethnic Medicine, Jiangxi University of Chinese Medicine

2. Guizhou Bailing Enterprise Group Pharmaceutical Co., Ltd.

3. College of Humanities, Jiangxi University of Chinese Medicine

4. Medical Clinic, Jiangxi University of Chinese Medicine

Publisher

Pharmaceutical Society of Japan

Link

https://www.jstage.jst.go.jp/article/bpb/47/3/47_b24-00052/_pdf

Reference58 articles.

1. 1) Li J, Chen J, Liang J. Consensus opinion on the combined diagnosis and treatment of cholelithiasis with traditional and western medicine. Chin. J. Integr. Tradit. West. Med. Dig, 26, 132–138 (2018).

2. 2) Wang Y, Zhang W, Wang X. A review of the risk factors for cholelithiasis in China. Chin. J. Mult. Organ. Dis. Elderly, 17, 636–640 (2019).

3. 3) Ding P, Wang Z. Research progress in the treatment of gallstones by traditional medicine. Zhongchengyao, 41, 1125–1128 (2019).

4. 4) Liu H, Ni X, Sheng S. Treatment status and meditation of benign gallbladder diseases. Zhonghua Xiaohua Waike Zazhi, 20, 813–819 (2020).

5. 5) Hand TW, Vujkovic-Cvijin I, Ridaura VK, Belkaid Y. Linking the microbiota, chronic disease, and the immune system. Trends Endocrinol. Metab., 27, 831–843 (2016).